Drimva

GenBio AI

Vice President of Business & Corporate Development

$300K–$400K

Palo Alto, CA · On-site · Director · Full-time · Posted Oct 8, 2026

Experience
Roughly 12+ years of relevant experience; meaningful tenure in both big pharma and a smaller entrepreneurial environment.
Education
MD, PhD, or Master’s in biology or a related scientific field, plus an MBA or equivalent hands-on operating experience.
Visa sponsorship
GenBio AI participates in the U.S. Department of Homeland Security’s E-Verify program to confirm the employment eligibility of all newly hired employees.

About the job

Leads GenBio AI’s commercial strategy, business model, strategic partnerships, and corporate development for its AI-driven virtual-cell platform.

What you'll do

  • Define commercial strategy, business model, partnership approach, pricing, and monetization.
  • Originate, negotiate, and close strategic partnerships, licensing, collaboration, and co-development opportunities.
  • Represent the company with senior industry leaders and coordinate internal teams to advance opportunities.

What they ask for

  • MD, PhD, or Master’s in biology or a related scientific field, plus an MBA or equivalent hands-on operating experience.
  • Roughly 12+ years of relevant experience, including meaningful tenure in both big pharma and a smaller entrepreneurial environment.
  • Personally sourced, negotiated, and closed several meaningful licensing, platform, or collaboration deals.
  • Deep understanding of pharmaceutical R&D and AI/ML or computational approaches in life sciences; fluent written and spoken English.

Nice to have

  • Experience with AI-native, computational biology, drug discovery, or emerging technology platforms.
  • Experience building a business development team or commercial function in an early-stage or high-growth company.

Pay

USD 300,000–400,000 per year (base salary)

Tools

AIDO, AIDO Cell, AIDO Foundry, AIDO Lab, AI/ML

AI focus

Commercializes and develops partnerships for AI-driven virtual-cell modeling and related computational biology applications.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)